# The ILLUMINA Study. (ILLUMINA)

Study · id `cardio:ct-nct03510676` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03510676](<https://clinicaltrials.gov/study/NCT03510676>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03510676

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03510676. Allocation not applicable; no masking; primary purpose treatment. Start 2016-01-26 (actual); primary completion 2018-03-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03510676, source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)
- Started: 2016-01-26 (actual) (ClinicalTrials.gov record NCT03510676, source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)
- Primary completion: 2018-03-07 (actual) (ClinicalTrials.gov record NCT03510676, source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)
- Completion: 2019-03-07 (actual) (ClinicalTrials.gov record NCT03510676, source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)
- Countries: France; Germany; Italy (ClinicalTrials.gov record NCT03510676, source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03510676-2021-07-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: The ILLUMINA Study. (ILLUMINA)
- Acronym: ILLUMINA
- Condition: Peripheral Arterial Disease
- Intervention (Device): NiTiDES
- Lead sponsor: CID - Carbostent & Implantable Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: 260e0db3ef6a3db8043e132bd5b91af1f37f000e77f9e31ae575f30be1c8d05c
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
